Details of the Drug Formulations | DrugMAP

General Information of Drug (ID: DMUQ1DO)

Drug Name

ITI-007 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Depression	6A70-6A7Z	Phase 3	[1]
Insomnia	7A00-7A0Z	Phase 3	[2]
Schizophrenia	6A20	Phase 3	[2]
Major depressive disorder	6A70.3	Phase 2	[1]

Cross-matching ID

PubChem CID: 21302490
CAS Number: 313369-37-8
TTD ID: D0Q0EF
ACDINA ID: D01228

Full List of Drug Formulations Containing This Drug

Lumateperone 42mg capsule

Company	Formulation ID	FDA Description
Intra-Cellular	F23219	Croscarmellose Sodium; Gelatin; Magnesium Stearate; Mannitol; Talc; Titanium Dioxide; Fd&C Blue 1; Red 3
------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	ClinicalTrials.gov (NCT02469155) A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment.